Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer

Dual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomised Clinical Trial

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Dual-port laparoscopic gastrectomy (DPLG) has been widely performed in recent years for treating gastric cancers. The present study explore the safety and effect of dual-port laparoscopic distal gastrectomy (DPLDG).

Who May Be Eligible (Plain English)

Who May Qualify: 1. patients within 18--75 years old; 2. patients with a preoperative pathological diagnosis of gastric adenocarcinoma; 3. patients with a clinical tumor stage of T1N1,T2N0 according to the preoperative examinations (gastroscopy, ultrasound gastroscopy and computed tomography); 4. patients with a plan to undergo laparoscopic distal gastrectomy and obtain R0 surgical results; 5. patients without severe heart, liver, lung, or kidney dysfunction; 6. patients with an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-1; and (7) patients with American Society of Anesthesiologists (ASA) I-II. Who Should NOT Join This Trial: 1. patients with a history of upperabdominal surgery; 2. patients who presentedas an emergency case; 3. patients with other histories of malignant diseases within 5 years; 4. patients with prior neoadjuvant chemotherapy or radiation therapy; and (5)patients who need simultaneous surgical treatment for other malignant diseases. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. patients within 18--75 years old; 2. patients with a preoperative pathological diagnosis of gastric adenocarcinoma; 3. patients with a clinical tumor stage of T1N1,T2N0 according to the preoperative examinations (gastroscopy, ultrasound gastroscopy and computed tomography); 4. patients with a plan to undergo laparoscopic distal gastrectomy and obtain R0 surgical results; 5. patients without severe heart, liver, lung, or kidney dysfunction; 6. patients with an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-1; and (7) patients with American Society of Anesthesiologists (ASA) I-II. Exclusion Criteria: 1. patients with a history of upperabdominal surgery; 2. patients who presentedas an emergency case; 3. patients with other histories of malignant diseases within 5 years; 4. patients with prior neoadjuvant chemotherapy or radiation therapy; and (5)patients who need simultaneous surgical treatment for other malignant diseases.

Treatments Being Tested

PROCEDURE

DPLDG

Dual-port laparoscopic distal gastrectomy

PROCEDURE

LDG

Laparoscopic distal gastrectomy

Locations (1)

Nanfang Hospital
Guangzhou, Guangdong, China